BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12439363)

  • 1. Past and present attempts to prevent radiocontrast nephropathy.
    Bailey SR
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S14-8. PubMed ID: 12439363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiocontrast-induced acute renal failure: allocations and outcomes.
    Mehran R; Ashby DT
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
    Duong MH; MacKenzie TA; Malenka DJ
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of radiocontrast-induced nephropathy.
    Baker CS
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):532-8. PubMed ID: 12652507
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiocontrast nephropathy: the dye is not cast.
    Lepor NE
    Rev Cardiovasc Med; 2000; 1(1):43-54. PubMed ID: 12457151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
    Mathur VS
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
    Madyoon H
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of intravenous contrast-induced nephropathy in hospital inpatients.
    Kakkar R; Sobieszczyk P; Binkert CA; Faxon DP; Mortele KJ; Singh AK
    Crit Pathw Cardiol; 2008 Mar; 7(1):1-4. PubMed ID: 18458660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephropathy caused by radiocontrast media].
    Kolarz M; Sułowicz W
    Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
    Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy.
    Forman JP
    N Engl J Med; 2004 Feb; 350(8):836-8; author reply 836-8. PubMed ID: 14978836
    [No Abstract]   [Full Text] [Related]  

  • 14. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
    Kini AA; Sharma SK
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
    Bagshaw SM; McAlister FA; Manns BJ; Ghali WA
    Arch Intern Med; 2006 Jan; 166(2):161-6. PubMed ID: 16432083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiocontrast-induced nephropathy.
    Porter GA
    Nephrol Dial Transplant; 1994; 9 Suppl 4():146-56. PubMed ID: 7800248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contrast-induced acute renal failure].
    Giannattasio M
    G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast nephropathy: review focusing on prevention.
    Maeder M; Klein M; Fehr T; Rickli H
    J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiocontrast-induced nephropathy.
    Asif A; Preston RA; Roth D
    Am J Ther; 2003; 10(2):137-47. PubMed ID: 12629594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.